Abstract
11P Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have